AMENDMENT NO. 1 TO COOPERATION AGREEMENTCooperation Agreement • September 9th, 2021 • Cytrx Corp • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 9th, 2021 Company IndustryThis Amendment No. 1 to the Cooperation Agreement (this “Amendment”), effective as of September 2, 2021, amends the Cooperation Agreement, (the “Agreement”) effective as of August 21, 2020, by and between CytRx Corporation, a Delaware corporation (the “Company”), and Jerald A. Hammann and his Affiliates (collectively, “Hammann”). The Company and Hammann are together referred to herein as the “Parties,” and each, a “Party.” Unless otherwise defined herein, capitalized terms shall have the meanings given to them in the Agreement.